HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Meta-analysis
Network meta-analysis of classical TCM formulas as adjuncts to antihistamines for chronic spontaneous urticaria.
Chinese Herbs May Stop Hives From Coming Back
This network meta-analysis of 5,814 patients with chronic spontaneous urticaria synthesized evidence on classical TCM formulas as adjuncts t…
Combining traditional Chinese herbs with standard allergy medicine may help people with stubborn hives feel better sooner and keep the rash …
Frontiers
Apr 22, 2026
Pediatrics
Cohort
Retrospective case series evaluates omalizumab efficacy in Chinese pediatric chronic spontaneous urticaria patients.
This Hives Medicine Might Help Young Children Finally Find Relief
This retrospective case series assessed omalizumab in 13 Chinese children under 12 years with chronic spontaneous urticaria. Specific effica…
A common hives drug shows promise for younger kids who usually have few options.
Frontiers
Apr 21, 2026
Dermatology
Phase III
Phase 3 Study Evaluates Barzolvolimab for Chronic Spontaneous Urticaria
Can a new treatment finally help those suffering from chronic hives?
A Phase 3 trial assesses barzolvolimab's efficacy and safety in CSU patients unresponsive to antihistamines.
Adults with chronic hives who don't get relief from standard antihistamines may find new hope in a new treatment called barzolvolimab being …
CT.gov
Mar 28, 2026